KIR3DS1 is presumed to be an NK cell activation receptor. The gene has many ( greater than 40) inhibitory alleles, known as KIR3DL1. Various KIR3DL1 subtypes have been shown to interact directly with HLA-I proteins with the Bw4 public epitope. Regardless of its similarity to KIR3DL1, and its established role in HIV disease, KIR3DS1 has only recently been shown to be expressed on NK cells and no ligand has been described. Toward an understanding of KIR3DS1 ligand binding we developed a reporter system for the engagement of KIR3DS1. The system uses KIR3DS1 fused to the T cell receptor zeta signaling chain. In addition, we have established HLA Bw4 (B5701) expressing cell lines. These cell lines are infected with lentiviral vectors and combined with the reporter line. Thus far, lentiviral infection does not result in the activation of the KIR3DS1 reporter system. In addition, we have induced stress in these Bw4 expressing cells before combining them with the reporter cells. We also have identified key residues of KIR3DS1 that do not exist in KIR3DL1. Through mutagensis we have shown that W138 of KIR3DS1 is critically involved in the lack of recognition of HLA-Bw4 by KIR3DS1. Reversion of W138 to G found in KIR3DL1 confers Bw4 binding without affecting the expression or antibody recognition of the receptor.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIABC010747-05
Application #
8157428
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
2010
Total Cost
$97,945
Indirect Cost
Name
National Cancer Institute Division of Basic Sciences
Department
Type
DUNS #
City
State
Country
Zip Code
Pymm, Phillip; Illing, Patricia T; Ramarathinam, Sri H et al. (2017) MHC-I peptides get out of the groove and enable a novel mechanism of HIV-1 escape. Nat Struct Mol Biol 24:387-394
Benoit, Bernice M; Jariwala, Neha; O'Connor, Geraldine et al. (2017) CD164 identifies CD4+ T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214. Arch Dermatol Res 309:11-19
McCullen, M V; Li, H; Cam, M et al. (2016) Analysis of Ly49 gene transcripts in mature NK cells supports a role for the Pro1 element in gene activation, not gene expression. Genes Immun 17:349-57
Saunders, Philippa M; Pymm, Phillip; Pietra, Gabriella et al. (2016) Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition. J Exp Med 213:791-807
Augusto, Danillo G; O'Connor, Geraldine M; Lobo-Alves, Sara C et al. (2015) Pemphigus is associated with KIR3DL2 expression levels and provides evidence that KIR3DL2 may bind HLA-A3 and A11 in vivo. Eur J Immunol 45:2052-60
O'Connor, Geraldine M; Vivian, Julian P; Gostick, Emma et al. (2015) Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1. J Virol 89:5213-21
Saunders, Philippa M; Vivian, Julian P; Baschuk, Nikola et al. (2015) The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope. J Immunol 194:781-789
O'Connor, Geraldine M; Vivian, Julian P; Widjaja, Jacqueline M et al. (2014) Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity. J Immunol 192:2875-84
O'Connor, Geraldine M; McVicar, Daniel (2013) The yin-yang of KIR3DL1/S1: molecular mechanisms and cellular function. Crit Rev Immunol 33:203-18
O'Connor, Geraldine M; Seich Al Basatena, Nafisa-Katrin; Olavarria, Viviana et al. (2012) In contrast to HIV, KIR3DS1 does not influence outcome in HTLV-1 retroviral infection. Hum Immunol 73:783-7

Showing the most recent 10 out of 15 publications